1. Home
  2. OCGN vs ACCO Comparison

OCGN vs ACCO Comparison

Compare OCGN & ACCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCGN
  • ACCO
  • Stock Information
  • Founded
  • OCGN 2013
  • ACCO 1893
  • Country
  • OCGN United States
  • ACCO United States
  • Employees
  • OCGN N/A
  • ACCO N/A
  • Industry
  • OCGN Biotechnology: Biological Products (No Diagnostic Substances)
  • ACCO Publishing
  • Sector
  • OCGN Health Care
  • ACCO Consumer Discretionary
  • Exchange
  • OCGN Nasdaq
  • ACCO Nasdaq
  • Market Cap
  • OCGN 278.3M
  • ACCO 321.7M
  • IPO Year
  • OCGN N/A
  • ACCO N/A
  • Fundamental
  • Price
  • OCGN $1.06
  • ACCO $3.36
  • Analyst Decision
  • OCGN Strong Buy
  • ACCO Buy
  • Analyst Count
  • OCGN 3
  • ACCO 1
  • Target Price
  • OCGN $6.00
  • ACCO $6.00
  • AVG Volume (30 Days)
  • OCGN 6.3M
  • ACCO 887.3K
  • Earning Date
  • OCGN 08-07-2025
  • ACCO 07-31-2025
  • Dividend Yield
  • OCGN N/A
  • ACCO 8.90%
  • EPS Growth
  • OCGN N/A
  • ACCO N/A
  • EPS
  • OCGN N/A
  • ACCO N/A
  • Revenue
  • OCGN $4,522,000.00
  • ACCO $1,624,700,000.00
  • Revenue This Year
  • OCGN N/A
  • ACCO N/A
  • Revenue Next Year
  • OCGN N/A
  • ACCO $0.58
  • P/E Ratio
  • OCGN N/A
  • ACCO N/A
  • Revenue Growth
  • OCGN N/A
  • ACCO N/A
  • 52 Week Low
  • OCGN $0.52
  • ACCO $3.32
  • 52 Week High
  • OCGN $1.98
  • ACCO $6.44
  • Technical
  • Relative Strength Index (RSI)
  • OCGN 59.49
  • ACCO 34.11
  • Support Level
  • OCGN $1.10
  • ACCO $3.43
  • Resistance Level
  • OCGN $1.29
  • ACCO $3.88
  • Average True Range (ATR)
  • OCGN 0.10
  • ACCO 0.11
  • MACD
  • OCGN -0.00
  • ACCO -0.03
  • Stochastic Oscillator
  • OCGN 53.06
  • ACCO 7.14

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

About ACCO Acco Brands Corporation

ACCO Brands Corp designs, manufactures, and markets consumer and business products. It operates through two segments: ACCO Brands Americas, and ACCO Brands International. The company offers school notebooks, janitorial supplies, and whiteboards; storage and organization products, sheet protectors, and indexes, and punching products; computer accessories and others used in schools, homes, and businesses. The company markets and sells its products through various channels, including mass retailers; e-tailers; discount, and variety chains; and warehouse clubs. It generates maximum profit from ACCO Brands America segment.

Share on Social Networks: